Related Experiment Video
Updated: Oct 25, 2025

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
Published on: February 24, 2021
Neuronal-driven glioma growth requires Gαi1 and Gαi3
Yin Wang1, Yuan-Yuan Liu2, Min-Bin Chen3
1Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, China.
Abstract:
Neuroligin-3 (NLGN3) is necessary and sufficient to promote glioma cell growth. The recruitment of Gαi1/3 to the ligand-activated receptor tyrosine kinases (RTKs) is essential for mediating oncogenic signaling. Methods: Various genetic strategies were utilized to examine the requirement of Gαi1/3 in NLGN3-driven glioma cell growth. Results: NLGN3-induced Akt-mTORC1 and Erk activation was inhibited by decreasing Gαi1/3 expression. In contrast ectopic Gαi1/3 overexpression enhanced NLGN3-induced signaling. In glioma cells, NLGN3-induced cell growth, proliferation and migration were attenuated by Gαi1/3 depletion with shRNA, but facilitated with Gαi1/3 overexpression. Significantly, Gαi1/3 silencing inhibited orthotopic growth of patient-derived glioma xenografts in mouse brain, whereas forced Gαi1/3-overexpression in primary glioma xenografts significantly enhanced growth. The growth of brain-metastatic human lung cancer cells in mouse brain was largely inhibited with Gαi1/3 silencing. It was however expedited with ectopic Gαi1/3 overexpression. In human glioma Gαi3 upregulation was detected, correlating with poor prognosis. Conclusion: Gαi1/3 mediation of NLGN3-induced signaling is essential for neuronal-driven glioma growth.
Insights
Neuroligin-3 (NLGN3) drives glioma growth by recruiting Gαi1/3 proteins. Inhibiting Gαi1/3 reduces glioma and lung cancer brain metastasis, highlighting Gαi1/3 as a therapeutic target.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cancer signaling pathways
Background:
- Neuroligin-3 (NLGN3) is implicated in promoting glioma cell growth.
- G protein alpha subunit i1/3 (Gαi1/3) recruitment to receptor tyrosine kinases (RTKs) is crucial for oncogenic signaling.
Purpose of the Study:
- To investigate the role of Gαi1/3 in NLGN3-mediated glioma cell growth and signaling.
- To determine if Gαi1/3 is a potential therapeutic target for glioma and brain metastasis.
Main Methods:
- Genetic strategies including shRNA-mediated depletion and ectopic overexpression of Gαi1/3.
- Analysis of Akt-mTORC1 and Erk signaling pathway activation.
- Assessment of glioma cell growth, proliferation, and migration in vitro.
- Evaluation of tumor growth in orthotopic xenograft models (glioma and brain-metastatic lung cancer) in mice.
Main Results:
- NLGN3-induced Akt-mTORC1 and Erk activation were dependent on Gαi1/3 expression levels.
- Gαi1/3 depletion attenuated NLGN3-driven glioma cell growth, proliferation, and migration.
- Gαi1/3 silencing inhibited orthotopic glioma and brain metastasis growth, while overexpression enhanced it.
- Gαi3 upregulation in human glioma correlated with poor prognosis.
Conclusions:
- Gαi1/3 is essential for NLGN3-induced oncogenic signaling and glioma cell growth.
- Targeting Gαi1/3 presents a promising therapeutic strategy for glioma and brain metastasis.
More Related Videos
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
Related Concept Videos
Activation and Inactivation of G Proteins
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
IP3/DAG Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...